Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.58 |
| ▸ | FGFR1 | P11362 | 8/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | LTA4H | P09960 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6661764 | 0.83 | HDAC6 (0.59) | HDAC6FGFR1LTA4H | |
| SCHEMBL8327824 | 0.79 | HDAC6 (0.59) | HDAC6FGFR1HTTLTA4HALDH1A1 | |
| SCHEMBL8326090 | 0.78 | HDAC6 (0.58) | HDAC6FGFR1HTTALDH1A1 | |
| SCHEMBL4352301 | 0.74 | HTT (0.58) | FGFR1HTTSRC | |
| SCHEMBL17187986 | 0.73 | HDAC6 (0.55) | HDAC6FGFR1SRC | |
| SCHEMBL6879124 | 0.72 | HDAC6 (0.40) | HDAC6HTTLTA4HALDH1A1 | |
| SCHEMBL23438813 | 0.72 | ATM (0.43) | FGFR1HTTALDH1A1 | |
| SCHEMBL680855 | 0.71 | FGFR1 (0.56) | FGFR1HTTLTA4HSRCALDH1A1 | |
| SCHEMBL30662366 | 0.71 | RPS6KA5 (0.51) | FGFR1HTTSRCALDH1A1 | |
| SCHEMBL11900775 | 0.71 | FGFR1 (0.75) | FGFR1HTTSRCALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220216426-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-07 | — | — | US | disclosed |
| WO-2021135182-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
| EP-1444982-A1 | The use of purine derivatives as selective kinase inhibitors | MERCKLE GMBH (DE) | 2004-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220216426-A1 | NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND ELECTRONIC APPARATUS | NCL, DNMT3A, NUDT1 | HDAC6 4177/4885FGFR1 3962/4885HTT 248/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.